20 (AIDX) Operating Leases (2024 - 2026)

20's (AIDX) quarterly Operating Leases came in at $429122.0 in Q1 2026, down 12.2% on a QoQ basis from $488725.0 in Q4 2025.

20 (AIDX) Operating Leases (2024 - 2026) Analysis & Trends

20 (AIDX) has 3 years of Operating Leases data on file, last reported at $429122.0 in Q1 2026.

Quarterly Operating Leases changed N/A year-over-year to $429122.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $429122.0 (changed N/A YoY) and the FY2025 annual result came in at $488725.0, down 27.47% from the prior year.
Operating Leases slipped to $429122.0 in Q1 2026, from $488725.0 in the prior quarter.
In the past five years, Operating Leases ranged from a high of $673848.0 in Q4 2024 to a low of $429122.0 in Q1 2026.
A 3-year average of $530565.0 and a median of $488725.0 in 2025 frame the typical range for Operating Leases.
The widest YoY moves for Operating Leases: up 27.47% in 2025, down 27.47% in 2025.
Tracing AIDX's Operating Leases over 3 years: stood at $673848.0 in 2024, then retreated by 27.47% to $488725.0 in 2025, then declined by 12.2% to $429122.0 in 2026.
The last three Operating Leases figures came in at $429122.0 (Q1 2026), $488725.0 (Q4 2025), and $673848.0 (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn
10	20	5.45 Mn	905,333.06	304,727.00

Download Data